Alkermes (ALKS) Net Margin (2010 - 2026)
Alkermes' Net Margin came in at 3.39% for Q3 2026, down 17.60 percentage points from 21.00% a year earlier but up 3.29 percentage points from the prior quarter.
Alkermes (ALKS) Net Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Alkermes reported Net Margin of -0.02%, down 22.29 percentage points year-over-year; for FY2025, it was 16.37%, down 7.19 percentage points from FY2024.
- Net Margin carries a five-year change of +27.05 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was 23.57% in FY2024 (+2.18 pp), 21.39% in FY2023 (+35.62 pp), -14.24% in FY2022 (-10.13 pp) and -4.10% in FY2021 (+6.57 pp).
- The five-year range for quarterly Net Margin is -25.35% (Q3 2022) to 38.40% (Q2 2023).
- Year-over-year, Net Margin has declined for seven consecutive quarters, with an average year-over-year change of -11.04 percentage points over the last eight quarters.
- The fastest year-over-year change in Net Margin over five years came in Q2 2023 (a gain of 49.31 percentage points), and the weakest in Q1 2026 (a drop of 24.25 percentage points).
- Business Quant data shows ALKS's Net Margin at 0.10% (Q2 2026), -16.92% (Q1 2026) and 12.83% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 19.55% |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 3.39% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.39% |
| Jun 30, 2026 | 0.10% |
| Mar 31, 2026 | -16.92% |
| Dec 31, 2025 | 12.83% |
| Sep 30, 2025 | 21.00% |
| Jun 30, 2025 | 22.30% |
| Mar 31, 2025 | 7.33% |
| Dec 31, 2024 | 34.07% |
| Sep 30, 2024 | 24.43% |
| Jun 30, 2024 | 22.89% |
| Mar 31, 2024 | 10.51% |
| Dec 31, 2023 | 29.88% |
| Sep 30, 2023 | 12.54% |
| Jun 30, 2023 | 38.40% |
| Mar 31, 2023 | -14.55% |
| Dec 31, 2022 | -9.27% |
| Sep 30, 2022 | -25.35% |
| Jun 30, 2022 | -10.91% |
| Mar 31, 2022 | -12.89% |
| Dec 31, 2021 | 0.27% |
Alkermes Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();